GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenith Drugs Ltd (NSE:ZENITHDRUG) » Definitions » Net Income Including Noncontrolling Interests

Zenith Drugs (NSE:ZENITHDRUG) Net Income Including Noncontrolling Interests : ₹96 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Zenith Drugs Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Zenith Drugs's Net Income Including Noncontrolling Interests for the six months ended in Mar. 2024 was ₹43 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ₹96 Mil.

Zenith Drugs Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Zenith Drugs's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Drugs Net Income Including Noncontrolling Interests Chart

Zenith Drugs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Net Income Including Noncontrolling Interests
30.29 31.29 48.80 96.47

Zenith Drugs Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24
Net Income Including Noncontrolling Interests - - - 53.94 42.53

Zenith Drugs Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Drugs Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Zenith Drugs's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenith Drugs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenith Drugs Ltd (NSE:ZENITHDRUG) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
NSE:SOTAC BOM:532637 BOM:524202 BOM:524661 NSE:PAR BOM:537536 BOM:531592 BOM:524828 NSE:MADHAVBAUG BOM:524412 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
K. No. 72 / 5, Village Muradpura, NA Depalpur, Indore, MP, IND, 453001
Website
https://www.zenithdrugs.com
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules. It is also into Generic Medicines.

Zenith Drugs Headlines

No Headlines